Company & Sponsor Intelligence
MedtronicNeuro
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting0
Completed5
Countries2
Therapeutic footprint
epilepsypain_neuropathyparkinsonsstroke
Indexed studies
NCT02844465Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT00101933SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy
epilepsy · PHASE3
epilepsy · PHASE3
NCT01098565Deep Brain Stimulation Effects Study
parkinsons · GermanyPHASE1
parkinsons · GermanyPHASE1
NCT01032239SISTERS: Spasticity In Stroke Study - Randomized Study
stroke · United StatesPHASE4
stroke · United StatesPHASE4
NCT06499220Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)
pain_neuropathy · United StatesNA
pain_neuropathy · United StatesNA
NCT01850498Epilepsy Motion Sensing
epilepsy · United StatesCOMPLETED
epilepsy · United StatesCOMPLETED
NCT03446833LFP Beta aDBS Feasibility Study
parkinsons · United StatesNA
parkinsons · United StatesNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →